MedTrace Logo

The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples

NCT01631162 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2012-06-29

No results posted yet for this study

Summary

The investigators assume that by analysis of different volatile organic compounds in the breath, using nanotechnology, the investigators will be able to identify a unique respiratory signature of different diseases including asthma, chronic obstructive pulmonary disease (COPD) and pulmonary hypertension.

Conditions

  • Asthma
  • Chronic Obstructive Lung Disease

Interventions

OTHER

Breath sample in all patients

Breath sample will be collected by a special nylon bag

Sponsors & Collaborators

  • Carmel Medical Center

    lead OTHER

Principal Investigators

  • Amer Ubaid · Carmel Medical Center

  • Yochai Adir, PI · Carmel Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2014-12-31
Completion
2015-06-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01631162 on ClinicalTrials.gov